Article,
Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Affiliations
- [1] Sapienza Univ Rome, Dept Clin Internal Med Anaesthesiol & Cardiovasc S, I-00161 Rome, Italy [NORA names: Italy; Europe, EU; OECD];
- [2] Heart & Chest Hosp, Liverpool L7 8TX, England [NORA names: United Kingdom; Europe, Non-EU; OECD];
- [3] Univ Liverpool, Liverpool John Moores Univ & Liverpool, Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg, Liverpool L7 8TX, Lancashire, England [NORA names: United Kingdom; Europe, Non-EU; OECD];
- [4] Univ Roma Tor Vergata, Dept Econ & Finance, Via Columbia 2, I-00133 Rome, Italy [NORA names: Italy; Europe, EU; OECD];
- [5] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, Aalborg, Denmark [NORA names: AAU Aalborg University; University; Denmark; Europe, EU; Nordic; OECD]
Abstract
Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.
Keywords
bleeding,
coronary artery disease,
major adverse cardiovascular events,
peripheral artery disease,
rivaroxaban